American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6387)
  2. Solid Tumor Oncology Division (5528)
  3. Survivorship Research (1993)
  4. Genitourinary Oncology Service (1766)
  5. Surgery (1634)
  6. Epidemiology and Biostatistics (1492)
  7. GSK Faculty (1387)
  8. Population Sciences Research Program (1374)
  9. Gastrointestinal Oncology Service (1352)
  10. Hematologic Malignancies, Division of (1277)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2561)
  3. Editorial (73)
  4. Review (65)
  5. Guidelines (54)
  6. Correspondence (48)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6387)
  2. Solid Tumor Oncology Division (5528)
  3. Survivorship Research (1993)
  4. Genitourinary Oncology Service (1766)
  5. Surgery (1634)
  6. Epidemiology and Biostatistics (1492)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (250)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8678)
  2. JCO Precision Oncology (166)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (4)

More Publications

Results (9142)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial differences in organic anion transport proteins (OATP) and outcome in castration resistant prostate cancer treated with AR pathway inhibitors in Alliance A031201: A phase III trial
    Meeting Abstract

    Ryan, C. J.; Kim, H.; Morris, M. J.; Alyamani, M.; Diaz, R.; Beltran, H.; Armstrong, A. J.; Sharifi, N.; Halabi, S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Darolutamide monotherapy in patients with castration-sensitive prostate cancer (CSPC) after biochemical recurrence (BCR): ARAMON lead-in phase results
    Meeting Abstract

    Laccetti, A. L.; Smith, M. R.; Scher, H. I.; Nowfar, S.; Einstein, D. J.; Martin, B.; Adorjan, P.; Dissanayake, M.; Verholen, F.; Gao, X.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC)
    Meeting Abstract

    Madsen, K. N.; Labaki, C.; Saad, E.; Alchoueiry, M.; Bi, K.; Hobeika, C.; Bakouny, Z.; Priolo, C.; Khabibullin, D.; Schindler, N. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cognitive effects of androgen receptor (AR) directed therapies for advanced cancer of the prostate (COGCaP): A comparison of enzalutamide vs abiraterone acetate
    Meeting Abstract

    Morgans, A. K.; Ma, Y.; Jackson, J. C.; Ryan, C. J.; Moses, K. A.; Barata, P. C.; Dorff, T. B.; Kocherginsky, M.; Vanderweele, D. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effects of emerin dysregulation on the very-small-nuclear phenotype and neuronal differentiation and its association with a clinically aggressive subtype of prostate cancer
    Meeting Abstract

    Zhang, L.; Teng, P. C.; Cavassani, K. A.; Grasso, C.; Watson, J.; Wang, J. J.; Chen, Z.; Tu, K. H.; Salumbides, B.; Gevorkian, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Preferred treatment regimens for rare genitourinary (GU) malignancies
    Meeting Abstract

    Simon, N. I.; Berg, S. A.; Tan, A.; Chandran, E.; Atiq, S. O.; Kydd, A. R.; Cordes, L. M.; Mortazavi, A.; Reimers, M. A.; Milowsky, M. I.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Incidence and mortality trends in genitourinary cancer in Southeast Asia from 1990-2021
    Meeting Abstract

    Columbres, R. C. A.; Selokar, A.; Sha, S.; Ranganathan, S.; Wu, J. F.; Feliciano, E.; Mahal, B. A.; Nguyen, P. L.; Dee, E. C. C.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A liquid biopsy-based proteomic assay to identify circulating tumor cell (CTC) -derived druggable targets in cancer patients
    Meeting Abstract

    Horrmann, A.; Arafa, A.; Kamalanathan, K.; Hesch, A.; Schaap, G.; Izuora, Z.; Ahmadi, M.; Konety, B. R.; Scher, H. I.; Antonarakis, E. S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world treatment pattern and clinical outcomes among patients with metastatic renal cell (mRCC) carcinoma post PD-1/PD-L1 immuno-oncology (IO) therapies
    Meeting Abstract

    Shah, N. J.; Ravilla, R.; Osterland, A. J.; Todoroff, K.; Wang, C. Y.; Rane, P.; Saal, H.; Wang, D.; Motzer, R. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes
    Meeting Abstract

    Zarrabi, K. K.; Ababio, Y.; Eccleston, A.; Rao, Drnj; Kelly, S.; Chang, J. E.; Adejumo, K. L.; Lucht, S.; Paydar, C.; Van Doren, B. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save